| Specialty Retail Industry | Consumer Discretionary Sector | Ms. Lan Dai CEO | SSE Exchange | CNE100005NV3 ISIN |
| CN Country | 846 Employees | 10 Jun 2026 Last Dividend | 25 May 2023 Last Split | - IPO Date |
Bide Pharmatech Co., Ltd., founded in 2007 and headquartered in Shanghai, China, is a dynamic entity that is involved in the research, development, production, and sale of pharmaceutical products. With a focus on contributing significantly to the realms of life sciences, organic chemistry, materials science, and analytical chemistry, the company has established itself as a noteworthy player in the Chinese pharmaceutical industry. The expertise and commitment to innovation have positioned Bide Pharmatech as a trusted partner for various stakeholders in the pharmaceutical and related sectors.
Development and distribution of pharmaceuticals and solutions aimed at advancing life sciences research. These products facilitate the study of biological processes and diseases, with the goal of discovering and developing new therapies.
Provision of a comprehensive array of chemicals and reagents critical for organic synthesis, including building blocks, reagents, and catalysts for researchers in academia and industry engaged in chemical synthesis and drug discovery.
Supply of high-quality materials science products that support the development and testing of novel materials. This includes the production of chemicals and compounds used in the creation of new materials with unique properties for various applications.
Offering an extensive portfolio of products for analytical chemistry applications, Bide Pharmatech aids in the precise measurement and analysis of chemical substances. These products are crucial for quality control, regulatory compliance, and research and development in both the pharmaceutical and chemical industries.